1.
Alan Celik, Dahl LS, Garly R, Glavicic V, Sharma MB, Yammeni S, et al. Impact of age and comorbidities on real-world outcomes in advanced breast cancer patients treated with palbociclib in first line: a nation-wide Danish retrospective study. AO [Internet]. 2025 Jun. 11 [cited 2026 Apr. 22];64:778-83. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/43226